How much vitamin C does Gabiroba contain?

Gabiroba (Campomanesia xanthocarpa) contains approximately 312.21 mg of ascorbic acid per 100g of fresh fruit pulp, which is roughly 3 to 4 times the vitamin C content found in oranges. This high concentration contributes meaningfully to its antioxidant activity and supports its traditional use as a nutritionally rich fruit in the Brazilian Cerrado region.

Is Campomanesia xanthocarpa effective for lowering blood sugar?

Animal studies using leaf and fruit extracts of Campomanesia xanthocarpa have reported reductions in fasting blood glucose in streptozotocin-induced diabetic rodent models, suggesting a potential hypoglycemic effect possibly mediated by alpha-glucosidase inhibition by tannins and flavonoids. However, no human clinical trials have been conducted, so it cannot currently be recommended as a blood sugar management strategy in people with diabetes or prediabetes.

What antioxidant compounds are found in Gabiroba?

Gabiroba fruit and leaves contain a range of phenolic antioxidants including quercetin glycosides, gallic acid, ellagitannins, condensed tannins (proanthocyanidins), and ascorbic acid, with the peel and seed fractions typically showing higher total phenolic content than the pulp. These compounds have demonstrated free radical scavenging activity in DPPH and ABTS assays, with the fruit peel extract often recording the highest antioxidant capacity in comparative studies.

Can Gabiroba interact with any medications?

Campomanesia xanthocarpa has theoretical interaction potential with antidiabetic drugs such as metformin, glipizide, or insulin due to observed hypoglycemic effects in animal models, which could cause additive blood glucose lowering. Its high tannin content may also bind to and reduce the absorption of certain oral medications, particularly iron supplements and some antibiotics, so supplemental forms should be taken at least two hours apart from such drugs.

What is Gabiroba traditionally used for in Brazilian folk medicine?

In traditional Brazilian Cerrado medicine, Gabiroba leaves and fruit have been used to treat inflammatory conditions, digestive disorders including diarrhea and intestinal cramping, and as a general tonic believed to support liver and kidney function. These uses are attributed to its flavonoid and tannin content, though systematic ethnobotanical documentation remains limited and none of these traditional applications have been validated in controlled clinical studies.

What is the difference between fresh Gabiroba fruit and Gabiroba supplements or extracts?

Fresh Gabiroba fruit contains the whole food matrix with fiber, polyphenols, and vitamin C in their natural form, while supplements and extracts concentrate specific compounds like antioxidants and may have different bioavailability profiles. Processing methods (drying, extraction, standardization) can alter the nutrient composition and potency compared to whole fruit. Fresh fruit typically contains approximately 312.21 mg/100g vitamin C, whereas extract concentrations vary depending on the extraction method used.

Is Campomanesia xanthocarpa safe to take during pregnancy or while breastfeeding?

There is insufficient clinical evidence to establish the safety of Gabiroba supplementation during pregnancy or breastfeeding, as no human studies have been conducted in these populations. While traditional use in Brazilian medicine suggests historical consumption, pregnant and nursing women should consult with a healthcare provider before adding Gabiroba supplements to their routine. The high vitamin C content is generally safe in food amounts, but concentrated supplement forms warrant medical guidance.

What does the current research evidence show about Gabiroba's effectiveness for digestive health?

Current evidence for Gabiroba's digestive benefits is limited to traditional use documentation and preliminary in-vitro antioxidant studies, with no published clinical trials in humans specifically measuring digestive health outcomes. The antioxidant compounds identified through laboratory assays (DPPH, ABTS, ORAC) suggest theoretical anti-inflammatory potential relevant to digestive support, but this has not been validated in controlled human studies. More rigorous clinical research is needed to establish efficacy and appropriate dosing for digestive applications.

Campomanesia xanthocarpa (Gabiroba)

Campomanesia xanthocarpa (Gabiroba) is a Brazilian Cerrado fruit rich in flavonoids, tannins, and ascorbic acid that demonstrate antioxidant activity by neutralizing free radicals and chelating metal ions. Its phenolic compounds, particularly quercetin derivatives and gallic acid, are thought to underlie its traditional applications for inflammation and digestive complaints.

Category: Fruit Evidence: 2/10 Tier: Emerging

Campomanesia xanthocarpa (Gabiroba) — Hermetica Encyclopedia

Origin & History

Campomanesia xanthocarpa (Gabiroba) is a fruit-bearing tree from the Myrtaceae family native to Brazil's Atlantic Forest regions, particularly the South and Southern areas. The fruits and leaves are processed into extracts using ethanol:water (50:50 v/v) followed by acetone:water (70:30 v/v), or dried into whole fruit flour containing concentrated nutrients.

Historical & Cultural Context

In Brazilian folk medicine, Gabiroba has been traditionally used by local families to treat inflammatory conditions, renal issues, digestive diseases, and dyslipidemia. This traditional use is documented in South and Southern Brazil, though the duration of historical use is not specified in available sources.

Health Benefits

• Antioxidant activity demonstrated through DPPH, ABTS, TEAC, and ORAC assays (preliminary evidence from in-vitro studies only)
• High vitamin C content at 312.21 mg/100g may support immune function (based on nutrient analysis, no clinical trials)
• Traditional use for inflammatory and digestive conditions (historical use only, no clinical validation)
• Potential cardiovascular support shown by hypotensive effects in normotensive rats (animal study only, no human trials)
• Rich in carotenoids (290.84 μg/g total) including lutein (14.92 μg/g) which may support eye health (based on nutrient content only)

How It Works

The flavonoids and condensed tannins in Gabiroba scavenge reactive oxygen species by donating hydrogen atoms to free radicals, as measured by DPPH and ABTS assays, while quercetin glycosides may inhibit cyclooxygenase (COX-1 and COX-2) enzymes to reduce prostaglandin synthesis. Gallic acid and ellagitannins present in the fruit interact with NF-κB signaling pathways, potentially downregulating pro-inflammatory cytokines such as TNF-α and IL-6. Ascorbic acid at 312.21 mg/100g contributes to antioxidant activity by regenerating tocopherol and directly quenching singlet oxygen species.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses have been conducted on Campomanesia xanthocarpa. Current evidence is limited to preclinical studies, including hypotensive effects observed in normotensive rats using aqueous leaf extracts, and in-vitro antioxidant assays.

Clinical Summary

Evidence for Campomanesia xanthocarpa is currently limited to in-vitro assays and animal models, with no published randomized controlled trials in humans as of 2024. In-vitro antioxidant studies using DPPH, ABTS, TEAC, and ORAC methods have quantified strong radical-scavenging capacity in fruit pulp, peel, and seed extracts, with IC50 values comparable to standard antioxidants like Trolox. Rodent studies have explored hypoglycemic and antidyslipidemic effects of leaf and fruit extracts, showing reductions in fasting glucose and total cholesterol in streptozotocin-induced diabetic models, though these findings have not been validated in human populations. The overall evidence base is preliminary, and no therapeutic dosages or clinical outcomes have been established for human use.

Nutritional Profile

Campomanesia xanthocarpa (Gabiroba) is a nutrient-dense tropical fruit with the following documented composition per 100g fresh weight: Vitamin C (ascorbic acid): 312.21 mg/100g — exceptionally high, exceeding oranges (~53 mg/100g) by approximately 6-fold, contributing significantly to daily antioxidant intake. Total carbohydrates: approximately 8–12 g/100g, primarily simple sugars (fructose, glucose) with low glycemic burden. Dietary fiber: approximately 3–5 g/100g, including pectin fractions that may support gut motility. Moisture content: high, approximately 80–85 g/100g. Protein: low, approximately 0.8–1.2 g/100g. Lipids: minimal, approximately 0.3–0.6 g/100g. Minerals: potassium (~150–200 mg/100g, estimated), calcium, and phosphorus present at moderate levels though precise values remain incompletely characterized. Bioactive phenolic compounds include flavonoids (quercetin, myricetin glycosides), tannins, and ellagic acid derivatives identified via HPLC analyses. Total phenolic content reported between 150–400 mg GAE/100g depending on ripeness and extraction method. Carotenoids (beta-carotene, lutein) present at low levels. Bioavailability note: Vitamin C bioavailability is expected to be high given its water-soluble matrix; however, co-occurring tannins may partially inhibit mineral absorption. Phenolic bioavailability data from human studies is currently absent — existing evidence is limited to in-vitro extraction analyses.

Preparation & Dosage

No clinically studied dosage ranges are available due to the absence of human trials. Preclinical studies used extract concentrations of 100-1000 µg/mL for in-vitro assays, but these cannot be translated to human doses. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Lutein, Quercetin, Other Brazilian heritage fruits, Green tea polyphenols

Safety & Interactions

No clinical safety data or formal toxicology studies in humans have been published for Campomanesia xanthocarpa extracts or supplements as of 2024. Given its high tannin content, excessive consumption may inhibit non-heme iron absorption, which is a concern for individuals with iron-deficiency anemia or those relying on plant-based iron sources. The fruit's potential hypoglycemic activity observed in animal studies raises a theoretical risk of additive blood glucose lowering if combined with antidiabetic medications such as metformin or insulin. Pregnant and breastfeeding individuals should avoid supplemental doses due to the complete absence of safety data in these populations, though moderate dietary consumption of the whole fruit is generally considered traditional and low-risk.